Physician profile
Scott E Walker
NPI 1104840834
$766.38
in general payments reported to CMS, 2019-2025
11 companies · $77.63 in 2025
The $77.63 reported for 2025 was more than what a typical Nurse Anesthetist, Certified Registered provider received nationally (typical 2025 total: $45.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $199 · 2022: $236 · 2023: $121 · 2024: $133 · 2025: $77.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $331.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $331.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $353.56 | 2021-2025 | Bridion |
| Acacia Pharma INC | $87.19 | 2022 | |
| Chiesi USA, INC. | $62.62 | 2021-2022 | |
| Abbvie INC. | $54.62 | 2021-2022 | |
| Becton, Dickinson and Company | $50.99 | 2024 | Fluency Endovascular Stent Graft |
| Takeda Pharmaceuticals U.S.A., INC. | $43.40 | 2021-2022 | |
| Teleflex LLC | $34.68 | 2021-2024 | |
| Intercept Pharmaceuticals, INC. | $28.14 | 2021-2022 | |
| Baxter Healthcare | $19.78 | 2025 | Fluid Systems - Drug Delivery Systems |
| Eagle Pharmaceuticals, INC. | $15.83 | 2023 | |
| Olympus America INC. | $15.57 | 2024 | Uretero-Reno Videoscope |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.